Retraction notices

Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro

Type
Retraction
Notice date
2/13/2019 0:00
Journal
International Journal of Cancer
Publisher
Wiley
Notice DOI
10.1002/ijc.32130
Original paper DOI
10.1002/ijc.20917

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.